Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 702
Selected: 0
NCT IDTitle
NCT01838681Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT01349348Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
NCT04189705A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
NCT00665366Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
NCT00989573A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease
NCT03734302The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects
NCT00036127Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
NCT07649265A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
NCT00475319Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
NCT01240668Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
NCT02360319Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
NCT02476409Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
NCT03292848Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
NCT03605849A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
NCT00036114Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT00706589Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
NCT01048788A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg
NCT02859402Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
NCT07087327A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
NCT01299454A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
NCT01567527Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
NCT01702831Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
NCT02160145Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
NCT00094432A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
NCT01802866Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
NCT01360645Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
NCT01111552Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT01349335Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT00237913Schizophrenia Trial of Aripiprazole
NCT01723059Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
NCT06036108Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
NCT01292304Tolvaptan for Ascites in Cirrhotic Patients
NCT00201955Study of Rebamipide Eye Drops to Treat Dry Eye
NCT01628848A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients
NCT00043758Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT02446132Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT04115319A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
NCT05418101A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)
NCT00524498A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma
NCT01095016A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
NCT03018691Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
NCT01447576Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
NCT04092686A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
NCT02012218Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
NCT00511082Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
NCT02336347A Phase 1 Study Comparing AVP-786 With AVP-923
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia
NCT07461220Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
NCT00948090PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients